BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 17255269)

  • 21. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
    Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H
    Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
    Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.
    Rohr UP; Rehfeld N; Geddert H; Pflugfelder L; Bruns I; Neukirch J; Rohrbeck A; Grote HJ; Steidl U; Fenk R; Opalka B; Gabbert HE; Kronenwett R; Haas R
    Clin Cancer Res; 2005 Jan; 11(1):180-5. PubMed ID: 15671544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Loss of exons of FHIT gene and FHIT protein expression in Yunnan tin miners with lung cancer].
    Ruan YH; Gao Q; Zhang L; Hua HR; Cheng JL; Jin KW
    Ai Zheng; 2007 Jun; 26(6):607-12. PubMed ID: 17562266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer.
    Tomizawa Y; Iijima H; Nomoto T; Iwasaki Y; Otani Y; Tsuchiya S; Saito R; Dobashi K; Nakajima T; Mori M
    Lung Cancer; 2004 Dec; 46(3):305-12. PubMed ID: 15541815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer.
    Kettunen E; Salmenkivi K; Vuopala K; Toljamo T; Kuosma E; Norppa H; Knuutila S; Kaleva S; Huuskonen MS; Anttila S
    Lung Cancer; 2006 Nov; 54(2):169-76. PubMed ID: 16935392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer?
    de Fraipont F; Moro-Sibilot D; Michelland S; Brambilla E; Brambilla C; Favrot MC
    Lung Cancer; 2005 Nov; 50(2):199-209. PubMed ID: 16043258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced Fhit protein expression and loss of heterozygosity at FHIT gene in tumours from smoking and asbestos-exposed lung cancer patients.
    Pylkkanen L; Wolff H; Stjernvall T; Tuominen P; Sioris T; Karjalainen A; Anttila S; Husgafvel-Pursiainen K
    Int J Oncol; 2002 Feb; 20(2):285-90. PubMed ID: 11788890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer.
    Rehfeld N; Geddert H; Atamna A; Gabbert HE; Steidl U; Fenk R; Kronenwett R; Haas R; Rohr UP
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2232-8. PubMed ID: 17119051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer.
    Wistuba II; Behrens C; Virmani AK; Milchgrub S; Syed S; Lam S; Mackay B; Minna JD; Gazdar AF
    Cancer Res; 1999 Apr; 59(8):1973-9. PubMed ID: 10213509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancer.
    Sienel W; Mecklenburg I; Dango S; Ehrhardt P; Kirschbaum A; Passlick B; Pantel K
    Clin Cancer Res; 2007 Jul; 13(13):3840-7. PubMed ID: 17606715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
    Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
    Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer.
    Crowell RE; Gilliland FD; Temes RT; Harms HJ; Neft RE; Heaphy E; Auckley DH; Crooks LA; Jordan SW; Samet JM; Lechner JF; Belinsky SA
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):631-7. PubMed ID: 8824366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis.
    Sozzi G; Musso K; Ratcliffe C; Goldstraw P; Pierotti MA; Pastorino U
    Clin Cancer Res; 1999 Oct; 5(10):2689-92. PubMed ID: 10537330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of molecular abnormalities in bronchial brushings and tumor touch preparations.
    Barkan GA; Caraway NP; Jiang F; Zaidi TM; Fernandez R; Vaporcyin A; Morice R; Zhou X; Bekele BN; Katz RL
    Cancer; 2005 Feb; 105(1):35-43. PubMed ID: 15605362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program.
    Baryshnikova E; Destro A; Infante MV; Cavuto S; Cariboni U; Alloisio M; Ceresoli GL; Lutman R; Brambilla G; Chiesa G; Ravasi G; Roncalli M
    Clin Cancer Res; 2008 Mar; 14(6):1913-9. PubMed ID: 18347195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer.
    Machida EO; Brock MV; Hooker CM; Nakayama J; Ishida A; Amano J; Picchi MA; Belinsky SA; Herman JG; Taniguchi S; Baylin SB
    Cancer Res; 2006 Jun; 66(12):6210-8. PubMed ID: 16778195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer.
    Kang JU; Koo SH; Kwon KC; Park JW; Kim JM
    Cancer Genet Cytogenet; 2008 Apr; 182(1):1-11. PubMed ID: 18328944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alterations of FHIT gene and p16 gene in lung cancer and metastatic hilar lymph nodes].
    Wang X; Sun Y; Li W
    Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):108-11. PubMed ID: 11776848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas.
    Zheng H; Tsuneyama K; Takahashi H; Miwa S; Nomoto K; Saito H; Masuda S; Takano Y
    Anticancer Res; 2007; 27(1B):575-81. PubMed ID: 17348444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.